Risk Factors for Development of Acute Leukaemias and Myelodysplastic Syndromes in Nairobi

Robert K Bradley

Genetic and molecular basis for SRSF2 mutations in myelodysplasia

Leukaemia

Craig B Thompson

Role of IDH Mutations in Acute Myeloid Malignancies

Leukaemia

Scott Moore Carlson

The role of PRDM1 in epigenetic regulation and tumor suppression

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma

Effie W Petersdorf

Clinical Significance of MHC Haplotypes in HCT

Leukaemia

Laura B Freeman

Pooled Investigation of Pesticides and Lymphoma and Multiple Myeloma and Immunoproliferative Diseases in NCI and Cross-Canada Case-Control Studies

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

Genoveffa Franchini

T-Cell Transformation by Oncoviruses

Leukaemia

Hematology and hematologic malignancies Pathology

Charles D Blanke

SWOG Community Clinical Oncology Program Research Base

Trachea, bronchus and lung Prostate Melanoma of skin Leukaemia Kidney, renal pelvis and ureter Colorectum Cervix uteri Breast

Becca Asquith

KIR in adaptive immunity: in vivo relevance for human disease

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

Catherine Ju-Ying Wu

(PQD1) Impact of Cytotoxic and Targeted Therapy on Clonal Evolution of CLL

Leukaemia

Hematology and hematologic malignancies Pathology